Detalhe da pesquisa
1.
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114703
2.
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.
Mult Scler Relat Disord
; 76: 104803, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329786
3.
Is breastfeeding in MS harmful or not? An answer from real-world Czech data.
Mult Scler Relat Disord
; 76: 104790, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348317
4.
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry.
Front Neurol
; 13: 851426, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35518208
5.
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Mult Scler Relat Disord
; 54: 103104, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216998
6.
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS.
Front Neurol
; 11: 593527, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33510704